TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Decline in pulmonary function tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Progression to overt disseminated intravascular coagulopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: von Willebrand factor (vWf) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: TBG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: serum levels of leptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: foveal density (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whole density (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: choriocapillaris flow area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: post-implant survival
Endpoint domain: Mortality/survival
Primary endpoint: freedom from stroke
Endpoint domain: Adverse events/effects
Primary endpoint: Total amygdala volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of the stimulated left dorsolateral prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased survivin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact on health
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: sEMG values of the VAL muscle during step ascent and descent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Blood biomarkers of mucosal transcriptomic response (HIPK2 and PPP1CC expression changes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Support for bans on indoor tanning by minors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Intentions to allow indoor tanning
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Self-efficacy to refuse indoor tanning requests
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of participants requiring >100mg diazepam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin Resistance (HOMA-IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severe intraoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: knee valgus moments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: hip internal rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: hip adduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Low level of physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinically-defined PsP occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to rhythm checks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of time between doses of epinephrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of time between defibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse neurological outcomes (ASIA impairment score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: percentage of root contact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: miniscrew failure rate
Endpoint domain: Adverse events/effects
Primary endpoint: risk back flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Standardized hospitalization rates for ACSC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative social function improvement
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Nausea improvement
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Vomiting improvement
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Financial status improvement
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: urinary protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Detection of clinically significant PCa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: AUC of physical well-being scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: AUC of HSCT-specific and functional well-being scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: AUC of total FACT-BMT scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients opioid-free within 48 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported pain and functional recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in vaginal pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in VHI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in CTx levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of SABA-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in CD34+ HSPCs levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinopathy progression (odds ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facio-lingual apical deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facio-lingual angular deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cognitive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 3-year survival prediction
Endpoint domain: Mortality/survival
Primary endpoint: restoration/implant stability (Periotest value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ventilator- and vasopressor-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with cancer screening recommendations
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: psychiatric discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: weight gain (≥7%)
Endpoint domain: Adverse events/effects
Primary endpoint: nonresponse to treatment
Endpoint domain: Adverse events/effects
Primary endpoint: VAS mean knee pain during the last week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS mean knee pain during function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: range of active knee flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of intraoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of grade ≥2 neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: TFV‐DP levels ≥700 fmol/punch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No new HIV infections
Endpoint domain: Adverse events/effects
Primary endpoint: muscle strength in the 45° leg press
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stable vision at week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean level of fear of falling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Muscle mass increase (MTBB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength increase (1RMBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional performance improvement (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of predictive equations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in eGFR >30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: aphasia quotient (AQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of BC patients who did not exhibit G2 ARD
Endpoint domain: Adverse events/effects
Primary endpoint: Onset time of G2 ARD
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Life measured by Skindex-16 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adequate radiation dose in axillary level I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Radiation outcomes
Primary endpoint: Positive predictive value for detecting CA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful prediction of CA presence more than 6 months before clinical diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total reported sleep time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Conception rate within 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Duration needed to conceive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: ACL injury risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequacy of management by general practitioner
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in severity of rhinorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in post-nasal drip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 cases
Endpoint domain: Mortality/survival
Primary endpoint: COVID-19-related hospitalizations
Endpoint domain: Mortality/survival
Primary endpoint: Distal tipping of maxillary molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight-for-age z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: length-for-age z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: self-perceived functional performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: total Approaches to Dementia Questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dementia Knowledge Questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dementia Attitudes Scale total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oswestry Disability Index (ODI) threshold of 5
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: follow-up adherence scores
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Quality of life improvement (SF-36 score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Levels of thrombosis biomarkers (aPAI‐1, CLT, FXIa‐C1, sP‐selectin, D‐dimer)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reproducibility of dietary pattern scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity of dietary pattern scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MADRS score from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip flexor/extensor muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: selective motor control of ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Fugl‐Meyer Motor Function Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke‐Specific Quality of Life Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Apolipoprotein B100 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: GIA activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: decreased tissue fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced limb circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time in nonambulatory activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum UA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ses-IgE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ses-IgG4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Major perinatal morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Adherence to aspirin
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SBA titer of at least 128
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NRG‐1 plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weekly hours in structured activity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of consultations attended
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total errors in reports
Endpoint domain: Adverse events/effects
Primary endpoint: Days of postoperative delirium per person
Endpoint domain: Adverse events/effects
Primary endpoint: PHQ-9 score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in dysfunctional attitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of bacterial damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements on the irritability and lethargy/social withdrawal subscales of the ABC-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer forms of challenging behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital Anxiety and Depression Scale - Depression (HADS-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of Atrial Fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean ORTO-R score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: activity impairment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Accuracy of chest compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of mouth-to-mouth ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall performance ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First-pass success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ICIQ-UIsf score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinically relevant reduction in menopausal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute PJI
Endpoint domain: Mortality/survival
Primary endpoint: trunk flexors muscle strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: reduced low back symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Drop in PaCO2 at 1 hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for second dose of surfactant
Endpoint domain: Adverse events/effects
Primary endpoint: time until first rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores on postoperative day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triceps brachii sEMG activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rectus abdominis sEMG activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in tobacco smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive demand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical skills performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of clinical tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: persistence/effort
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Referrals suggested for pathogenic variants or VUS
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Further workup addressed (colonoscopy or esophagogastroduodenoscopy)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prioritization of SF reports for pathogenic variants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: BCVA change from baseline to month 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median forward-running time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Victorian Institute of Sports Assessment Scale-Achilles score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average plaque size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peyronie's Disease Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of MSGN
Endpoint domain: Mortality/survival
Primary endpoint: Decrease of fasting plasma glucose (FPG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease of postprandial glucose (PPG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvements in weight control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lateral Anal Tear (LAD) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Average maximum occlusal adjustment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean chair-side time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean laboratory time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Good awareness of common NCDs screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: successful 4-week outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PNsIgG4 in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PNsIgA/total IgA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Late toxicities (grade ≥ 3)
Endpoint domain: Adverse events/effects
Primary endpoint: WOMAC pain subscore improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hip–Knee–Ankle (HKA) angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in MCQ and spelling posttest scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived affordability of the advertised medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: OSDI decrease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SICCA score decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in artificial tear substitute use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pleasantness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in plantar-flexor muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Inadequate hand-surface coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes